Chronic pulmonary diseases such as Cystic Fibrosis (CF), Chronic Obstructive Pulmonary Disease (COPD) or Chronic Thromboembolic Pulmonary Hypertension (CTEPH) are devastating diseases. These conditions severely impact the lives of patients as their quality of life is decreased. Additionally, the number of fatalities due to chronic lung diseases is twice as high as with lung cancer. Consequently, patients suffering from CF, COPD or CTEPH require constant surveillance and medication. In this context, functional imaging of the lungs is of paramount importance, and currently done by nuclear medicine requiring radioactive tracers.
LungMaps is designed to be a paradigm shift for functional lung imaging by enabling MRI instead of nuclear medicine techniques to enter the stage of monitoring and outcome prediction, reducing the radiation burden for patients. Thereby, therapy decisions will be monitored, adjusted, and validated, empowering physicians to improve the quality of a prolonged life for their patients.
LungMaps is designed for:
Healthy male volunteer (45y) | Perfusion-weighted (Qw) map
Study-ID: 1aaaa5517, MAGNETOM Sola
Study-ID: 1aaaa5570, MAGNETOM Avanto | Courtesy: Hannover Medical School, Hannover, Germany
COPD, female patient (44y) | Vw/Qw defect map
Many ventilation, perfusion, and matching defects can be seen in this Vw/Qw defect map.
Study-ID: 1aaaa5568, MAGNETOM Avanto | Courtesy: Hannover Medical School, Hannover, Germany
CF, female patient (24y) | Vw/Qw defect map
Timepoint 1:
Large ventilation defects can be seen in this Vw/Qw defect map.
